Published on :
The President of the European Commission Ursula von der Leyen threatened this Saturday, March 20, to block exports of the AstraZeneca vaccine if the European Union did not receive its deliveries first. </p><div> <p>« <em>We have the option of prohibiting any planned export. This is our message to AstraZeneca: respect your contract with Europe before you start delivering to other countries</em> "Said Ursula von der Leyen in an interview with the German media group <em>Funke</em>.
« All options are on the table Added the former German Minister of Defense in a clear warning, stressing that European leaders would take stock of the issue of deliveries next week.
A contractual procedure to resolve the conflict with the laboratory
The European Commission announced on Thursday that it would activate a contractual procedure to resolve the conflict with the AstraZeneca laboratory whose deliveries of anti-Covid vaccines are significantly lower than the figures initially planned.
This procedure is provided for in the vaccine supply contracts concluded by the EU. Each party has the opportunity to send a letter to the other party inviting them to participate in a dispute resolution procedure that will take place 20 days later between the executive leaders of the European Commission and the company.
AstraZeneca unable to deliver initially planned number of doses
The AstraZeneca laboratory is due to deliver 70 million doses of its anti-Covid vaccine in the second quarter, the use of which has been suspended by several countries. This is much less than the 180 million doses promised in the contract signed with the European Union.
In the first quarter, the EU is expected to have received a total of some 30 million doses of AstraZeneca, against 90 million planned by the Swedish-British pharmaceutical group.
While the American Pfizer has solved its difficulties in producing vaccines, “ there is great suspicion in European circles that the AstraZeneca group has sold the same doses several times and is not capable “As a result of ensuring its deliveries to the EU, underlined a senior European official.
Towards a ban on vaccine exports?
The mechanism to ban the export of vaccines falls first of all to the Member State where it is produced and the European Commission then gives the green light. This mechanism has only been used once, Italy blocking the export of 250,000 doses of AstraZeneca to Australia, arguing a “ persistent shortage ” as well as ” delays in deliveries ».
However, not all of the Twenty-Seven are in favor of an export ban. Countries like the Netherlands and Belgium, where much of the AstraZeneca vaccine is produced, call for caution.
►To read: Covid-19: the European Medicines Agency judges the AstraZeneca vaccine “safe and effective”
Source site www.rfi.fr